Speaker Profile
CEO, Xella Health
Biography
Kelly Lacob is a healthcare technologist, product designer, and systems thinker working to make care more preventive, personalized, and accessible. Trained at Stanford and Johns Hopkins in human biology, bioengineering, and business, she has built her career translating early-stage science into scalable healthcare products for historically underserved populations.
Before co-founding Xella Health, Kelly led product design and roadmap development for the first CRISPR-powered diagnostic platform at Mammoth Biosciences, and helped develop and launch the first FDA-cleared point-of-care and at-home PCR test at Visby Medical—supporting early COVID-19 response efforts. Her work spans more than a dozen healthcare innovations, including remote monitoring platforms for chronic and maternal conditions, surgical supply solutions to reduce infection risk, community-based screening tools, and smart sensors for pressure sore prevention.
As Co-Founder and CEO of Xella Health, Kelly now focuses on bridging cutting-edge research and everyday clinical care for women and their families.
Talk
Decoding the Female Reproductive Healthspan & Enabling Early Intervention
Xella is pioneering a breakthrough method to monitor reproductive health using menstrual fluid instead of invasive biopsies. By using long-read DNA sequencing and proprietary computational methods, we can now separate and analyze "biological aging" signals from the reproductive system versus immune cells, revealing how reproductive organs age differently than the rest of the body.
Spatial Showcase:
Xella Health
Xella Health is a precision healthcare platform for women that leverages multi-omics, AI, and non-invasive testing to provide proactive prevention and early detection for reproductive health and gynecological disease. The company offers a convenient, personalized experience through an integrated patient portal and expert clinician team, ensuring that both patients and providers can easily interpret and act on predictive health insights.
